A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%

Launched by ALCON RESEARCH · Aug 30, 2011

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Sign Informed Consent document.
• • Diagnosis of open-angle glaucoma or ocular hypertension
• • Other protocol-specified inclusion criteria may apply.
• Exclusion Criteria:
• • Females of childbearing potential if pregnant, lactating, or not using highly effective birth control measures.
• • Severe central vision loss in either eye.
• • Any chronic or recurrent inflammatory eye disease.
• • Ocular trauma within the preceding 6 months.
• • Ocular infection or ocular inflammation within the preceding 3 months.
• • Best-corrected visual acuity score worse than 55 letters using the Early Treatment Diabetic Retinopathy Study chart.
• • Any intraocular surgery within the preceding 6 months.
• • Any ocular laser surgery within the preceding 3 months.
• • History or current evidence of severe illness or any other conditions which would make the subject, in the opinion of the Investigator, unsuitable for the study.
• • Other protocol-defined exclusion criteria may apply.

Trial Officials